Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial.
Alan J WiggJong K ChinKate R MullerJeyamani RamachandranRichard J WoodmanBillingsley KaambwaPublished in: Journal of gastroenterology and hepatology (2018)
The analysis of data from a randomized controlled trial suggests that the CDM intervention used is likely to be cost-effective, relative to usual care, due to fewer patient deaths.